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We examined 19 hepatoma tissues for alkaline phosphatase isoenzyme and found that six have both the Kasahara isoenzyme and an alkaline phosphatase with a unique electrophoretic mobility, in addition to the liver-type enzyme. From two of six carcinoma tissues, the abnormal enzyme was partly purified and subjected to a detailed analysis, which clarified that the abnormal enzyme resembled a fetal intestinal alkaline phosphatase in most of its enzymic and immunologic properties and also in properties that reflect enzyme structure. This fetal intestinal-type alkaline phosphatase was not found in 24 specimens of normal liver from adults. The relevance of fetal intestinal-type alkaline phosphatase to Kasahara isoenzyme and adult intestinal alkaline phosphatase is discussed. The fetal and adult intestinal alkaline phosphatases differ in electrophoretic mobility, heat stability, and reactivity with concanavalin A. The adult-type enzyme has two components; only the electrophoretically slower, neuraminidase-resistant one is described here.
Addftlonal Keyphrases: isoenzymes . cancer . discernible differences among isoenzymes . tissues of origin Human onco-fetal or onco-placental alkaline phosphatase (AP, orthophosphoric monoester phosphohydrolase, EC 3.1.3.1.) isoenzymes have been described by several laboratories.
These include the Regan isoenzyme, which is indistinguishable from the placental alkaline phosphatase (1, 2) ; the Nagao isoenzyme, which is identical with the placental D-variant isoenzyme (3) ; and the Kasahara isoenzyme, which resembles an alkaline phosphatase in FL[Fogh-Lund] -amnion cells (4, 5) . The Regan isoenzyme and the Nagao isoenzyme occur in various kinds of malignant tumors; the Kasahara isoenzyme, possibly identical with variant alkaline phosphatase (6) , occurs mainly in hepatoma (7) (8) (9) , although it may be present in carcinoma other than hepatoma (10) (11) (12) .
In addition to these isoenzymes, another alkaline phosphatase (13) has been reported, which may be a product of tumor tissues. To the best of Received Aug. 18, 1976; accepted June 3, 1977. our knowledge, however, the occurrence of a fetal intestinal-type alkaline phosphatase in carcinoma tissue had not been reported.
Here, we present evidence for a unique alkaline phosphatase in hepatoma tissue. This new enzyme was given the short-hand notation "Fl-type AP," which stands for fetal intestinal-type alkaline phosphatase. Fl-type AP occurs concomitantly with the Kasahara isoenzyme in hepatoma tissue and has certain enzymic and antigenic similarities to a fetal intestinal-type alkaline phosphatase.
We discuss the enzyme's similarity in antigenic determinants and catalytic properties, especially to the Kasahara isoenzyme. Fetal intestine was supplied by Dr. M. Yoshimura (Medical Examiner's Office, Osaka) and intestine and the hepatoma tissue from adults were obtained at autopsy. Tissues were obtained 6 to 15 h after death and stored at -20 #{176}C for one to 12 months. The electrophoretic mobility of the enzymes in these tissues did not change during storage.
MaterIals and Methods

Reagents
Enzyme Assay
Alkaline phosphatase activity was measured at 37 #{176}C, with phenyl phosphate or p-nitrophenyl phosphate as substrates, as described previously (14) . Protein was determined by the method of Lowry et al. (15) or from the absorbance at 280 nm.
Electrophoresis
For thin-layer horizontal elect rophoresis on poiyacrylamide gel (2 mm thick gels)we used Cyanogum prepared in 0.19 mol/liter tris(hydroxymethyl)aminomethane.HC1, pH 8.9, and borate (0.3 mol/liter, pH 8.0) as an electrode buffer, at constant current (1.0 mA/cm) for 4 h at 4 #{176}C. Cyanogum was prepared by mixing two parts of monomer mixture [9.5 g of acrylamide and 0.5 g of bis(N,N'-methylenebisacrylamide) in 100 ml of gel buffer], one part of ammonium persulfate (1.2 g/liter), and one part of N,N'-tetramethylene diamine (70 mmol/liter) (4).
The method used for electrophoresis in polyacrylamide gels of graded porosity was essentially that described by Andersson et al. (16) . All the equipment for gel electrophoresis was from Pharmacia Fine Chemicals, Uppsala, Sweden. Polyacrylamide gel having a continuous concentration gradient from 50 to 260 g/liter in a buffer (89 mmol/liter tris(hydroxymethyl)aminomethane, 82 mmol/liter boric acid, pH 8.35) was prepared by using their Gradient Mixer GM-i and Penstaltik Pump P-3 and sandwiched between vertical glass plates (8 X 8 cm) in their Gel Slab Casting Apparatus GSC-8. After the prerun for 30 mm at a constant voltage (125 V), 10 tl of a mixture consisting of a part of the sufficient concentration of the sample, a half part of bromophenol blue, and one part of 2 mol/liter sucrose was applied to the gel plate inserted between the cathodic chamber (above) and the anodic chamber (below) of the Electrophoresis Apparatus GE-4. After migration of the sample into the gel by pre-electrophoresis (30 mm, 65 V, 10 #{176}C) with the same buffer as the electrode buffer, electrophoresis was performed for 17 h at 125 V, with circulation of the buffer. After electrophoresis, the glass plates were removed from the gel.
Enzyme bands in the gels were made visible by incubating the gel in the dark at 37 #{176}C for about 20 mm with a staining solution of sodium a-naphthyl phosphate (100 mg) and Fast Blue BB salt (200 mg) in tris(hydroxymethyl)aminomethane hydrochloride (0.1 mol/liter, pH 9.0) containing MgCl2, 1 mmol/liter.
Preparative
isoelectric focusing of alkaline phosphatases in polyacrylamide gelswas done at 1 #{176}C in the M-137-LP apparatus, (MRA Corp., Boston, Mass.) by use of 16-cm glass tubes, 2.0 cm i.d., according to the method as described by Suzuki et al. (17) . Ampholyte ("Ampholine 81"; LKB Produkter, Bromma 1, Sweden), pH range 3-10, in a final concentration 10 g/liter, was used. The tubes were precooled for 2 h at 1 #{176}C and the whole apparatus was thermally insulated. A preliminary gradient was formed by prerunning the gels at a constant current of 16 mA per tube for 30 mm. Thereafter, the samples in solution containing 2.0 ml of enzyme solution (4mg of protein), 25mg of ampholyte, and 150 mg of sucrose in 2.5 ml of water were applied to the gels. Electrofocusing was allowed to proceed overnight at a constant voltage of 400 V and a final current of about 5 mA from an MS Type-30T regulated power supply. After 16 h of electrophoresis, the gels were removed from the tubes by injecting water from a syringe, cut into pieces 0.5 cm wide with a sharp knife and minced with scissors. The alkaline phosphatases were eluted into 4.0 ml of water. After measuring the pH, we assayed an aliquot for alkaline phosphatase activity.
Preparation and Partial Purification of Alkaline Phosphatase
Alkaline phosphatase was extracted from the tissue by a modification of Morton's procedure (18) . n-Butanol extracts from various tissues were treated with acetone and the fraction precipitating between 30 to 60% (by volume) acetone was dialyzed vs. 50 to 100 mmol/ liter tris(hydroxymethyl)aminomethane.HC1 buffer, pH 7.9. After this step, fetal intestinal alkaline phosphatase gave only one band of activity on a thin-layer horizontal polyacrylamide-gel electropherogram, but it gave three bands on the electropherogram resulting from use of the polyacrylamide gels of graded porosity described above. The respective molecular weights, tentatively determined, were 258 000 ± 18 000, 193 000 ± 18 000, and 155 000 ± 22 000. Neuraminidase treatment resulted in the slowing of the electrophoretic mobility for the larger two components, but not for the smallest. Since Fl-type AP was resistant to the action of neuraminidase, we compared it with the smallest component of fetal intestinal alkaline phosphatase. This component was obtained by preparative isoelectric focusing (17) and was shown to be free from contamination with other alkaline phosphatases.
The loading of the gels was sufficient to see other activities had they been present in significant amounts.
It was previously reported that adult intestinal alkaline phosphatase usually contains two components having different electrophoretic mobility (19) . In our preliminary experiments, the faster-migrating enzyme was retarded in its electrophoretic mobility by neuraminidase treatment while the slower enzyme retained its original mobility. To obtain the latter enzyme, we removed the intestinal mucosa by gently scraping the jejunum and ileum with a fine glass rod. The material released with the glass rod was extracted with n-butanol, followed by a differential acetone fractionation (30-60% by vol). The enzyme was further purified by chromatography on diethylaminoethyl-cellulose and gel filtration on Sephadex G-200, by a slight modification of our previously described procedure (4). Unless stated otherwise, the term "adult intestinal alkaline phosphatase" will be used to describe the slower-migrating component.
The Kasahara isoenzyme from hepatoma was prepared in a similar manner (4) . Its rate of anodal migration as compared with fetal intestinal alkaline phosphatase and adult intestinal alkaline phosphatase is shown in Figure 1 .
Preparation of Antibodies against the Kasahara lsoenzyme and Adult Intestinal Alkaline Phosphatase
The antisera to Kasahara isoenzyme was the same as that previously described (20) .
Antibody against purified adult intestinal alkaline phosphatase was produced by injecting subcutaneously 
. Elutlon profile of alkaline phosphatase from DEAE-cellulose
The 30 to 80% acetone fractIon (540mg of protein, with a specific activity of 0.7 mol phenol/mm per mg protein) of an n-butanol extract of hepatoma tissue was applied to a DEAE-cellulose column (2 X 44 cm) previously equilibrated with 0.1 mol/liter Trls44Cl, pH7.9. After washing the column with the same buffer, alkaline phosphatase was eluted with a linear gradient between 0.1 and 0.2 mol/Ilter Trls4'iCI, 20-mI fractions werecollected, and fractIons 30-70 were pooled.Enzyme activity was measured In a 0.1 ml-allquot of each fraction the mixture of antigen (about 200 g) and an equal volume of complete Freund's adjuvant (Difco Laboratories, Detroit, Mich. 48232) into rabbits. A booster injection was given two weeks later. The antibody-rich y-globulin fraction isolated from the anti-serum by ainmonium sulfate fractionation (0-40% saturation) was used in these studies.
Immunologic Studies
Antigenic similarities between various enzymes were determined by micro-Ouchterlony immunodiffusion assay (21). Briefly described, the immunodiffusion was performed on microscope slides coated with agar (12 g/liter). Diffusion was allowed to proceed for 24-48 h at 4 #{176}C. After washing with borate buffer (20 mmol/liter pH 8.0, in 0.15 mol/liter saline), the slides were flooded with the same substrate solution that we used to stain electrophoretic gels and incubated for about 20 mm at 37 #{176}C. Precipitin lines were made visible with the sub- 
Results
Evidence Suggesting the Occurrence of a Fetal Intestinal-type
Alkaline Phosphatase The fraction of the extract from hepatoma tissue precipitated by 30 to 60% acetone (by vol) was applied to diethylaminoethyl-cellulose and eluted by a linear gradient concentration of tris(hydroxymethyl)aminomethane'HCl buffer (pH 7.9) from 0.1 to 0.2 mol/liter (4). This procedure resulted in the separation of two peaks of alkaline phosphatase activity as is shown in Figure 2 . Peak A, which was eluted before the Kasahara isoenzyme (represented by peak B), was electrophoretically shown to have two enzyme components: the liver-type enzyme, which was predominant, and a unique enzyme, observed as a faint band anodal to but continuous with the liver-type enzyme on thin-layer polyacrylamide gel electrophoresis (Figure 3a ). This band was resistant to the action of neuraminidase, suggesting that it is an isoenzyme that is different from either the liver-type or Kasahara isoenzyme, both of which are sensitive to neuraminidase.
After treatment with neuraminidase (5 U/iO mg) at 37 #{176}C for 16 h, the unique enzyme could be separated from the liver enzyme by column chromatography on diethylaminoethyl-cellulose.
The enzyme so obtained was uncon- Specific activity of alkaline phosphatases(micromoles of phenol/mm per mg of protein) was 0.7 and 0.9 for Fl-type AP, 0.5 and 2.0 for fetal Intestinal alkaline phosphatase. and 3.7 and 21.5 for adult intestinal alkaline phosphatase. Respective enzymes with different specific activities were from different specimens of different purification steps. 
(5) taminated with other alkaline phosphatases, according to electrophoresis (Figure 3b) . Preliminary experiments showed that this alkaline phosphatase was inhibited by L-phenylalanine but not by L-homoarginine when these compounds were present in the staining mixture as described previously (22) . The electrophoretic mobility of this enzyme corresponded to that of fetal intestinal alkaline phosphatase on thin-layer polyacrylamide gel electropherogram ( Figure  3a) . Additional comparisons between Fl-type AP, fetal intestinal alkaline phosphatase and adult intestinal alkaline phosphatase were made and are reported below.
Comparison of Enzymic and Immunologic
Properties among Alkaline Phosphatases
Fl-type AP, and fetal-and adult-intestinal alkaline-phosphatase were similar in their behavior towards various inhibitors and treatments.
The effects of Lphenylalanine, L-tryptophan, L-leucine, and Lhomoarginine on the activity of these enzymes were compared at each concentrationgiven in Table 1 ,which
shows that phenylalanine, tryptophan, and leucine markedly inhibited all these enzymes, whereas Lhomoarginine did not significantly inhibit any. The inhibition patterns of Fl-type AP, fetal intestinal alkaline phosphatase, and adult intestinal alkaline phosphatase were similar except that FT-type AP was more insensitive to tryptophan than were the other two enzymes at 1 and 5 mmol/liter concentrations examined (P <0.02, by Student's t-test).
The effects of ethylenediaminetetraacetate, inorganic phosphate, and urea on these enzymes were also examined. The degree of inhibition caused by these three compounds was similar for all three enzymes ( Table 2, 3).
Table 3 also shows that there was no significant difference in the heat stability at 56 and at 65 #{176}C of Fl-type AP and adult intestinal alkaline phosphatase, but fetal intestinal alkaline phosphatase seemed to be slightly more stable than were the other two enzymes (P < 0.05). Mather and Keenan did their experiments with the human placental alkaline phosphatase at 15-mm incubation and at the ratio of sodium dodecyl sulfate/protein from 1/1 to 1000/1. They measured the activity in the presence of sodium dodecyl sulfate at the concentration used for incubation. They found that alkaline phosphatases appear to lose their activities rapidly in the first 2 h of incubation. The pH optima were very similar for three enzymes, as were the Michaelis constants, with phenyl phosphate as substrate (Table 4) .
All three alkaline phosphatases were also resistant to the action of neuraminidase with regard to electrophoretic mobility before and after treatment ( Table   4 ).
These collective results (Tables 1-4 ), together with our previous studies (4), led us to the conclusion that the Kasahara isoenzyme also resembled Fl-type AP, fetal intestinal alkaline phosphatase, and adult intestinal alkaline phosphatase in catalytic and enzymic properties. So additional experiments were undertaken to determine the similarity or difference among these enzymes.
The immunological relationship among the alkaline phosphatases as well as the Kasahara isoenzyme was examined by micro-Ouchterlony double diffusion. These enzymes evidently share an identical antigen site, since precipitin lines of each enzyme and the antibodies against either adult intestinal alkaline phosphatase or the Kasahara isoenzyme fused completely (Figure 4) .
Comparison of Other Properties Relating to Enzyme Structure
Sodium dodecyl sulfate is known to be an effective detergent for solubilizing membranous proteins and also an effective protein denaturant.
Most enzymes show a complete loss of activityaftersuch treatment. Mather and Keenan (23) found, however, that alkalinephosphatases are an exception.1 We examined the effect of this detergent on the activity of enzymes from various sources, with p-nitrophenyl phosphate as the substrate, and found that FT-type AP, fetal intestinal alkaline phosphatase, adult intestinal alkaline phosphatase, or the Kasahara isoenzyme each retained some of its activity after a 24-h incubation in sodium dodecyl sulfate, 5 and 50 g/liter, and the extent of inactivation was almost the same for each (Table 5 ). For reference, the effect of this compound on the placental alkaline phosphatase is also listed in the table, which indicates that the enzyme was inactivated almost completely even by a 1.5-h incubation in 5 g/liter sodium dodecyl sulfate. The reason for the difference in stability between the enzymes of intestinal and the placental origin is unknown. The usual explanation is that the oligomeric form binds little sodium dodecyl sulfate but the monomeric form binds more, which causes inactivation, as in the case of catalase (24), or that the enzyme repels sodium dodecyl sulfate because of its high negative charge, as in the case of pepsin (24) . Other explanations for the results obtained with these enzymes may be re- 
#{176}C.
Specific activity of alkaline phosphatases Is given in Table 1 . We performed experiments to determine if there was any difference in the reactivity of these enzymes to this compound. Its binding to the enzyme was examined, either by the change in electrophoretic mobility after binding (26) or by the production of a precipitin line having enzyme activity on micro-Ouchterlony double diffusion (27) . The Kasahara isoenzyme and FT-type AP remained near the origin after treatment with concanavalin A, while only a part of crude fetal intestinal enzyme preparation was found to be retarded in its mobility after such treatment.
The concanavalin A-reactive component of the crude preparation was found to correspond to the smallest molecular weight component (fetal intestinal alkaline phosphatase)
by the subsequent examination with the purified enzyme. The mobility of adult intestinal alkaline phosphatase was unaltered by this treatment ( Figure 5 ). Concanavalin A- at a final concentration of 50 g/liter (not shown). The Kasahara isoenzyme, fetal intestinal alkaline phosphatase, and Fl-type AP were also found to react with concanavalin A on micro-Ouchterlony double diffusion. The resulting precipitin line of identity suggests that fetal intestinal alkaline phosphatase, the Kasahara isoenzyme, and Fl-type AP have similar binding site(s) for concanavalin A ( Figure 6) .
We examined the occurrence of F I-type AP and the Kasahara isoenzyme in cancerous tissue (Table 6 ). Of the 19 primary hepatoma tissue extracts examined, six were found to possess both FT-type AP and the Kasahara isoenzyme, five extracts had only the Kasahara isoenzyme, and eight had neither. Therefore, we wondered whetherFl-type AP occurs concomitantly with the Kasahara isoenzyme in primary hepatoma. When carcinomas other than hepatoma were examined, we found that extracts from two stomach carcinomas, one pulmonary carcinoma, and two other carcinomas possessed the Kasahara isoenzyme, but none of them had FT-type AP. But because the activity of Fl-type AP is usually the total numbers of determinations with each two enzyme preparations.
C The source of the placental alkaline phosphatase was human placentas, obtained at full-term delivery and kept at -20 #{176}C until use. A mixture in the ratio of 25 g (wet wt)/75ml tris(hy&oxymethyl)aminomethane*lCl buffer (0.02 mol/liter, pH 7.4) was homogenized and the homogenate was extracted with one-half volume of n-butanol. The supemate obtained on centrifugation was further purlf led by acetone fractionation, D#{128}AE-ceilulose chromatography, and gel-filtration. We used both the enzyme at the acetone-fractionation step and that obtained ttwouph complete fractionation; both were Incubated with sodium dodecyl sulfate at the sodium dodecyl sulfate/protein ratio of about 10/1, 50/1. 500/1 (by wt). At 1.5 h incubation, their remaining enzyme activities were about 17%. 4.2 ± 1.1 %, and 1.8 ± 1.7%, respectIvely.
Specific activity of Fl-type AP, fetal intestinal alkaline phosphatase, and adult intestinal alkaline phosphatase is given in Table 1 . Specific activity of the other enzymes was 14.93 and 2.27 for placental alkaline phosphatase. and 1.3 and 5.1 for Kasahara isoenzyme.
lower than that of the Kasahara isoenzyme and because the Kasahara isoenzyme activity was low in the extracts which were Fl-type AP negative, we cannot conclude at present whether or not these two enzymes occur concomitantly in carcinoma.
Discussion
This report describes an alkaline phosphatase (Fltype AP) in hepatoma tissue that resembles fetal intestinal alkaline phosphatase in most of its enzymic and immunologic properties. The only differences we found between the two were in heat stability and the extent of inhibition by tryptophan, and these differences were slight. Moreover, these two alkaline phosphatases were also similar even in properties relating to enzyme structures such as reactivity with concanavalin A, insensitivity to neuraminidase, and stability in the presence of sodium dodecyl sulfate. So Fl-type AP seems to be almost identical with fetal intestinal alkaline phosphatase.
Fl-type AP is also similar to adult intestinal alkaline phosphatase in antigenic and catalytic properties, but is distinct in electrophoretic mobility and reactivity with concanavalin A. It would be evidence that Fl-type AP is an actual product of hepatoma tissue if two possibilities were to be ruled out. The first is that Fl-type AP is a normal liver product. To exclude this, we examined 24 specimens of normal adult liver for this enzyme. Of these, four had an enzyme which retained its original mobility after neuraminidase treatment. This neuraminidaseresistant enzyme, however, differed from Fl-type AP in electrophoretic mobility and heat stability (unpublished observation).
The second possibility is that FLtype AP in hepatoma tissue is derived from the blood stream after release of the enzyme from intestine or other organs. This hypothesis is unlikely, because a patient of blood type A, with Kasahara isoenzyme in both hepatoma tissue and serum, had Fl-type AP only in hepatoma tissue. Consequently, it seems unlikely that Fl-type AP in hepatoma occurred independently of carcinogenesis.
As for the possible relationship between FL-type AP and the Kasahara isoenzyme: These two alkaline phosphatases occurred concomitantly in hepatoma and were similar in immunologic and catalytic properties but differed in electrophoretic mobility, heat stability, and sensitivity to neuraminidase (4). As stated above, FL-type AP was almost identical with fetal intestinal alkaline phosphatase, whereas the Kasahara isoenzyme is identical with an alkaline phosphatase in FL-amnion cell (5) , a cell line established by Fogh and Lund
(28).
It is possible that Fl-type AP or fetal intestinal alkaline phosphatase is converted to the Kasahara isoenzyme though modification steps, for example by attachment or elongation of the carbohydrate moiety. We suggest this because the Kasahara isoenzyme differs from fetal intestinal alkaline phosphatase or Fl-type AP in electrophoretic mobility and sensitivity to neuraminidase. Both Kasahara and Fl-type AP may be the same with respect to catalytic site and antigenic site and possibly in amino acid sequence, but may differ in the composition and (or) structure of attached carbohydrate. But treatment of the Ksashara isoenzyme with neuraminidase did not give rise to fetal intestinal alkaline phosphatase or FL-type AP. Therefore, they do not appear to differ only in neuraminic acid content.
Anyway, we are sure that the Kasahara isoenzyme and Fl-type AP are different from normal liver isoenzyme. If these enzymes occurring in hepatoma arise after carcinogenesis, one could speculate that both enzymes reappear through de-differentiation (29) or disdifferentiation (30), so it is very important to analyze the primary structure of enzymes that are grouped according to similarity in catalytic properties and antigenic determinants.
Comparison of primary structure of the enzymes should render it possible to decide whether the Kasahara isoenzyme or Fl-type AP-or even carcinoma-are produced through epigenetic or genetic change. The latter possibility still remains since the Kasahara isoenzyme has not been found in amnion tissue of three-, four-, and 10-months gestation but only in FL-amnion cells (5) whose average chromosome number is unlike that of normal human cells (31, 32) .
Carcinoma tissues other than hepatoma were investigated for FL-type AP. We found that two stomachcarcinoma tissues in which the Kasahara isoenzyme was present lacked Fl-type AP as judged by electrophoretic analysis. The activity of Fl-type AP was always lower than that of Kasahara isoenzyme in the specimens examined. Therefore, the amount of Fl-type isoenzyme in other carcinoma tissue might be below the level of detection afforded by the method used in this study.
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